Biomerica, Inc. (NASDAQ:BMRA – Get Free Report) shares passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.86 and traded as low as $0.43. Biomerica shares last traded at $0.44, with a volume of 49,424 shares traded.
Biomerica Stock Performance
The stock has a market capitalization of $7.40 million, a price-to-earnings ratio of -1.19 and a beta of -0.97. The company has a fifty day simple moving average of $0.58 and a 200 day simple moving average of $0.86.
Biomerica (NASDAQ:BMRA – Get Free Report) last announced its earnings results on Friday, April 12th. The company reported ($0.11) EPS for the quarter. The company had revenue of $1.02 million for the quarter. Biomerica had a negative return on equity of 64.00% and a negative net margin of 117.46%.
Institutional Inflows and Outflows
About Biomerica
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
Recommended Stories
- Five stocks we like better than Biomerica
- Canadian Penny Stocks: Can They Make You Rich?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Stock Market Upgrades: What Are They?
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.